Association of apolipoprotein E 4 polymorphism with cerebral infarction in Chinese Han population

Acta Pharmacologica Sinica

Volumn 25, Issue 3, 2004, Pages 352-356

  Jin, Zhu Qing ^a   Fan, Yong Sheng ^a   Ding, Jing ^b   Chen, Mei ^c   Fan, Wei ^b   Zhang, Guang Ji ^a   Zhang, Bin Hui ^c   Yu, Suo Jing ^a   Zhang, Yong Sheng ^a   Ji, Wei Feng ^c   Zhang, Jian Gang ^d  

^a Zhejiang Medical College   (China)

^b FUDAN UNIVERSITY   (China)

^c Zhejiang Hospital of Traditional Chinese Medicine   (China)

^d NONE

Author keywords

Alleles; Apolipoproteins E; Brain infarction; Human; Polymorphism

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; ALLELE; APOE GENE; ARTICLE; BRAIN INFARCTION; CASE CONTROL STUDY; CHINESE; CHINESE HAN; CONTROLLED STUDY; FEMALE; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RISK FACTOR;

ADULT; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CHINA; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 12144290136     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Stegmayr B, Asplund K, Kuulasmaa K, Rajakangas AM, Thorvaldsen P, Tuomilehto J. Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project: an ecological study of 18 populations. Stroke 1997; 28: 1367-74.
2. Brass LM, Isaacsohn JL, Merikangas KR, Robinette CD. A study of twins and stroke. Stroke 1992; 23: 221-3.
3. Hrubec Z, Robinette CD. The study of human twins in medical research. N Engl J Med 1984; 310: 435-41.
4. Coyle P, Odenheimer DJ, Sing CF. Cerebral infarction after middle cerebral artery occlusion in progenies of spontaneously stroke-prone and normal rats. Stroke 1984; 15: 711-6.
5. Kiely DK, Wolf PA, Cupples LA, Beiser AS, Myers RH. Familial aggregation of stroke. The Framingham Study. Stroke 1993; 24: 1366-71.
6. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Gen 1993; 3: 256-9.
7. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-30.
8. Special report from the National Institute of Neurological Disorders and Stroke: classification of cerebrovascular diseases III. Stroke 1990; 21: 637-76.
9. Zhang MY, Katzman R, Salmon D, Jin H, Cai GJ, Wang ZY, et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender and education. Ann Neurol 1990; 27: 428-37
10. nd ed. Chinese ed). New York: Cold Spring Harbor Laboratory Press; 1989. p 465-6.
11. Russell H. 1989. Simple and rapid preparation of samples for PCR. In: Erlich HA, editor. New York: PCR Technology Stockton Press; 1989. p 31-8.
12. Hixon JE, Vernier DT. Restriction isotype of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-8.
13. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-9.
14. Hartl DL. Principles of population genetics. Sinauer: Sunderland, Mass; 1980.
15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
16. Utermann G, Langenback U, Beisiegel U, Weber W. Genetics of the apolipoprotein E system in man. Am J Hum Genet 1980; 32: 339-47.
17. Zannis VI, Breslow JL. Human VLDL apoE isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry 1981; 20: 1033-41.
18. Weisgraber KH, Rall SC Jr, Mehley RW. Human E apoprotein heterogeneity: cysteine-arginine interchanges in the amino acid sequence of the apoE isoforms. J Biol Chem 1981; 256: 9077-83.
19. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 1996; 19: 53-77.
20. Shigeji N, Kaori M, Nobuhiro Y. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342: 737.
21. Altstiel LD, Greenberg DA, Marin D, Lantz M, Mohs R. Apolipoprotein E genotype and cognition in the very old. Lancet 1997; 349: 1451.
22. Moore JH, Reilly SL, Ferrell RE, Sing CF. ApoE polymorphism may be a gender-specific predirector of coronary artery disease age of onset. Clin Genet 1997; 51: 22-5.
23. Bertomeu A, Ros E, Zambon D, Vela M, Perez-Ayuso RM, Targarona E, et al. Apolipoprotein E polymorphism and gallstones. Gastroenterology 1996; 111: 1603-10
24. Semenkovich CF, Heinecke JW. The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes 1997; 46: 327-34.
25. Kervinen K, Sodervik H, Makela J, Lehtola J, Niemi M, Kairaluoma MI, et al. ApoE polymorphism: another player in the genetics of colon cancer susceptibility? Gastroenterology 1996; 110: 1785-90.
26. Breslow JL, Zannis VI, SanGiacomo TR, Third JL, Tracy T, Glueck CJ. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J Lipid Res 1982; 23: 1224-35.
27. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J, Roquer J, D'Olhaberriague L, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992; 23: 1556-62.
28. Margaglione M, Seripa D, Gravina C, Grandone E, Vecchione G, Cappucci G, et al. Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian case-control study. Stroke 1998; 29: 399-403.
29. Peng DQ, Zhao SP, Wang JL. Lipoprotein (a), and apolipoprotein E 4 as independent risk factors for ischemic stroke. J Cardiovasc Risk 1999; 6: 1-6.
30. Kessler C, Spitzer C, Stauske D, Mende S, Stadlmuller J, Walther R, et al. The apolipoprotein E and β-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol 1997; 17: 2880-4.
31. Kokubo Y, Chowdhury AH, Date C, Yokoyam T, Sobue H, Tanaka H. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 2000; 31: 1299-306.
32. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke 1993; 24: 661-4.
33. Ferrucci L, Guralnik JM, Pahor M, Harris T, Corti MC, Hyman BT, et al. Apolipoprotein E 2 allele and risk of stroke in the older population. Stroke 1997; 28: 2410-6.
34. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, et al. Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 1996; 27: 1310-5.
35. Catto AJ, McCormack LJ, Mansfield MW, Carter AM, Bamford JM, Robinson P, et al. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand 2000; 101: 399-404
36. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 1995; 15: 1280-6.
37. MacLeod MJ, De Lange RP, Breen G, Meiklejohn D, Lemmon H, Clair DS. Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population. Eur J Clin Invest 2001; 31: 570-3.
38. Morrison AC, Ballantyne CM, Bray M, Chambless LE, Sharrett AR, Boerwinkle E. LPL polymorphism predicts stroke risk in men. Genet Epidemiol 2002; 22: 233-42.
39. Nakata Y, Katsuya T, Rakugi H, Takami S, Sato N, Kamide K, et al. Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am J Hypertens 1997; 10: 1391-5.
40. McCarron MO, Muir KW, Weir CJ, Dyker AG, Bone I, Nicoll JA, et al. The apolipoprotein E e4 allele and outcome in cerebrovascular disease. Stroke 1998; 29: 1882-7.
41. Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS. Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J Cereb Blood Flow Metab 1997; 17: 753-8.
42. Sheng H, Laskowitz DT, Bennett E, Schmechel DE, Bart RD, Saunders AM, et al. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J Cereb Blood Flow Metab 1998; 18: 361-6.
43. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
44. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science 2001; 291: 1304-51.
45. Hirakawa M, Tanaka T, Hashimoto Y, Kuroda M, Takagi T, Nakamura Y. JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res 2002; 30.